Excessive GH levels and, secondarily, insulin-like growth factor 1 (IGF-I) cause a range of complications, from changes in appearance to soft tissue and bone hypertrophy, leading to systemic disorders that result in shortened survival rates and reduced quality of life [1,2,3]. This evidence concerns the gene IGF1 and hyperostosis.